UroGen Pharma Ltd.
URGN
Jodie situation report
UroGen Pharma Ltd.'s current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 12 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 16 directly disclosed connections are confirming.
- URGN's market-adjusted activity becomes unusual and at least one connected name confirms.
Invalidation: The isolated read changes if URGN's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind URGN
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Depends on
TEVATeva Pharmaceutical Industries LimitedsupplierMar 2, 2026 ▾
“We currently depend on Teva Pharmaceuticals Industries Ltd, as our single-source supplier of mitomycin API for Jelmyto, Zusduri, UGN-103 and UGN-104.”
AGENFiling-linked namepartnerMar 2, 2026 ▾
“8 Table of Contents License and Acquisition Agreements Agenus Agreement In November 2019, we entered into a license agreement with Agenus, pursuant to which Agenus granted us an exclusive, worldwide (not including Argentina, Brazil, Chile, Colombia, Peru, Ven…”
Depended on by
RLMDRelmada Therapeutics, Inc.competitorMar 19, 2026 ▾
“Our chief competitors include companies such as Johnson and Johnson, CG Oncology, UroGen, Soleno Therapeutics, Aardvark Therapeutics, and Protara Therapeutics, among others.”
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks 13 more links, every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
URGN is currently a Follower in the organic co-movement group Biotechnology Innovators. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.
This group is retained as the last observed read for URGN; it is not active in the latest market snapshot.